Ritter, Melanie
Uhre, Valdemar
Christensen, Sofie Heidenheim
Korsbjerg, Nicoline Løcke Jepsen
Lønfeldt, Nicole Nadine
Pretzmann, Linea
Thoustrup, Christine Lykke
Mora-Jensen, Anna-Rosa Cecilie
JessicaPlessen, Kerstin
Jepsen, Jens Richard Møllegaard
Vangkilde, Signe
Uhre, Camilla Funch
Pagsberg, Anne Katrine
Blair, Robert James
Funding for this research was provided by:
Copenhagen University
Article History
Received: 30 October 2025
Accepted: 13 March 2026
First Online: 28 March 2026
<b>Declarations</b>
Ethics approval: The Ethics Committee of Capital Region of Denmark approval number: H-18010607.
Informed consent: Signed informed consent by parents/legal caregivers was collected.
Consent for publication: Not applicable (no potentially identifiable data included).
Trial registration number: ClinicalTrials.gov NCT03595098.
Competing interests: Valdemar Uhre is currently employed by Novo Nordisk. All other authors report no financial or other conflicts of interest